deltatrials
Completed PHASE4 INTERVENTIONAL NCT00520650

Health Evaluation of Abilify Long-term Therapy (HEALTH)

Sponsor: Taiwan Otsuka Pharm. Co., Ltd

Conditions Schizoaffective Disorder Schizophrenia
Interventions Aripiprazole
Updated 7 times since 2017 Last updated: Dec 15, 2009 Started: Aug 31, 2006 Primary completion: Apr 30, 2009 Completion: Apr 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Schizoaffective Disorder and Schizophrenia and is currently completed. Taiwan Otsuka Pharm. Co., Ltd leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshotCompleted~Dec 2025 – present · 7 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Dec 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2025 — Dec 2025 [monthly]

    Completed PHASE4

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Taiwan Otsuka Pharm. Co., Ltd
Data source: Taiwan Otsuka Pharm. Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations